172 related articles for article (PubMed ID: 25784226)
1. Histiocytoid sweet syndrome related to bortezomib: A mimicker of cutaneous infiltration by myeloma.
Llamas-Velasco M; Concha-Garzón MJ; Fraga J; Aragüés M
Indian J Dermatol Venereol Leprol; 2015; 81(3):305-6. PubMed ID: 25784226
[No Abstract] [Full Text] [Related]
2. Distinct variant of Sweet's syndrome: bortezomib-induced histiocytoid Sweet's syndrome in a patient with multiple myeloma.
Kim JS; Roh HS; Lee JW; Lee MW; Yu HJ
Int J Dermatol; 2012 Dec; 51(12):1491-3. PubMed ID: 22998496
[No Abstract] [Full Text] [Related]
3. Bortezomib-induced histiocytoid Sweet syndrome.
Murase JE; Wu JJ; Theate I; Cole GW; Barr RJ; Dyson SW
J Am Acad Dermatol; 2009 Mar; 60(3):496-7. PubMed ID: 19231647
[TBL] [Abstract][Full Text] [Related]
4. Bortezomib-induced Sweet syndrome.
Knoops L; Jacquemain A; Tennstedt D; Theate I; Ferrant A; Van den Neste E
Br J Haematol; 2005 Oct; 131(2):142. PubMed ID: 16197442
[No Abstract] [Full Text] [Related]
5. Histiocytoid Sweet syndrome.
Apalla Z; Kanatli L; Sotiriou E; Manousari A; Papagarifallou I; Calonje E
Clin Exp Dermatol; 2011 Jul; 36(5):562-3. PubMed ID: 21679369
[No Abstract] [Full Text] [Related]
6. Sweet-like syndrome induced by bortezomib.
Kolb-Mäurer A; Kneitz H; Goebeler M
J Dtsch Dermatol Ges; 2013 Dec; 11(12):1200-2. PubMed ID: 23905772
[No Abstract] [Full Text] [Related]
7. Atypical bortezomib-induced neutrophilic dermatosis.
Lescoat A; Dupuy A; Belhomme N; Stock N; Sebillot M; Decaux O; Jégo P; Droitcourt C
Ann Hematol; 2019 May; 98(5):1315-1316. PubMed ID: 30315343
[No Abstract] [Full Text] [Related]
8. Simmering Below the Surface: Sweet's Syndrome with Multiple Myeloma.
Singhi EK; Li BC; Denny JC
Am J Med; 2018 Sep; 131(9):1058-1060. PubMed ID: 29729238
[No Abstract] [Full Text] [Related]
9. Bortezomib-induced Sweet's syndrome confirmed by rechallenge.
Zobniw CM; Saad SA; Kostoff D; Barthel BG
Pharmacotherapy; 2014; 34(4):e18-21. PubMed ID: 24338786
[TBL] [Abstract][Full Text] [Related]
10. [Bortezomib-induced acute neutrophilic dermatosis].
Tanguy-Schmidt A; Avenel-Audran M; Croué A; Lissandre S; Dib M; Zidane-Marinnes M; Moles MP; Hunault-Berger M
Ann Dermatol Venereol; 2009 May; 136(5):443-6. PubMed ID: 19442803
[TBL] [Abstract][Full Text] [Related]
11. Histiocytoid Sweet syndrome may indicate leukemia cutis: a novel application of fluorescence in situ hybridization.
Chavan RN; Cappel MA; Ketterling RP; Wada DA; Rochet NM; Knudson R; Gibson LE
J Am Acad Dermatol; 2014 Jun; 70(6):1021-7. PubMed ID: 24636890
[TBL] [Abstract][Full Text] [Related]
12. Favorable outcome of severe, extensive, granulocyte colony-stimulating factor-induced, corticosteroid-resistant Sweet's syndrome treated with high-dose intravenous immunoglobulin.
Calixto R; Menezes Y; Ostronoff M; Sucupira A; Botelho LF; Florencio R; Martins M; Souto Maior AP
J Clin Oncol; 2014 Feb; 32(5):e1-2. PubMed ID: 24395855
[No Abstract] [Full Text] [Related]
13. Histiocytoid Sweet syndrome treated with azathioprine: a case report.
Miller J; Lee N; Sami N
Dermatol Online J; 2015 Jul; 21(7):. PubMed ID: 26436977
[TBL] [Abstract][Full Text] [Related]
14. Typically atypical: histiocytoid Sweet syndrome, associated with malignancy.
Hünermund A; Wendel AM; Geissinger E; Bröcker EB; Stoevesandt J
J Dtsch Dermatol Ges; 2011 Sep; 9(9):666-9. PubMed ID: 21884413
[TBL] [Abstract][Full Text] [Related]
15. Bortezomib-induced acute pancreatitis: Case report and review of the literature.
Talamo G; Sivik J; Pandey MK; Mir MA
J Oncol Pharm Pract; 2016 Apr; 22(2):332-4. PubMed ID: 25516544
[TBL] [Abstract][Full Text] [Related]
16. Panniculitis with histiocytoid/immature neutrophils is not limited to histiocytoid panniculitic Sweet syndrome.
Gerami P; Guitart J
Am J Dermatopathol; 2007 Dec; 29(6):596. PubMed ID: 18032966
[No Abstract] [Full Text] [Related]
17. Histiocytoid giant cellulitis-like Sweet's syndrome: case report and review of the literature.
So JK; Carlos CA; Frucht CS; Cohen PR
Dermatol Online J; 2015 Jan; 21(3):. PubMed ID: 25780979
[TBL] [Abstract][Full Text] [Related]
18. Management of tumor lysis syndrome in patients with multiple myeloma during bortezomib treatment.
Wang L; Jian Y; Yang G; Gao W; Wu Y; Zuo L
Clin J Oncol Nurs; 2015 Feb; 19(1):E4-7. PubMed ID: 25689664
[TBL] [Abstract][Full Text] [Related]
19. Bortezomib-induced syndrome of inappropriate antidiuresis in a patient with multiple myeloma: A case report and literature review
.
Peng B; Chen H; Lou X
Int J Clin Pharmacol Ther; 2017 Dec; 55(12):910-914. PubMed ID: 29092733
[TBL] [Abstract][Full Text] [Related]
20. Histiocytoid Sweet syndrome.
Wark KJ; Crawshaw H
Med J Aust; 2019 Nov; 211(9):400-400.e1. PubMed ID: 31625142
[No Abstract] [Full Text] [Related]
[Next] [New Search]
